HLA guided epitope discovery in Type 1 diabetes to generate novel therapeutics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
HLA guided epitope discovery in Type 1 diabetes to generate novel therapeutics ; volume:8 ; number:1 ; day:25 ; month:11 ; year:2010 ; pages:1 ; date:11.2010
Journal of translational medicine ; 8, Heft 1 (25.11.2010), 1, 11.2010
- Urheber
-
Peakman, M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-8-S1-I4
- URN
-
urn:nbn:de:1111-2016041436279
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Peakman, M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
ImmuneApp for HLA-I epitope prediction and immunopeptidome analysis
Charakterisierung HLA-A*01- sowie HLA-A*26-restringierter EBV-Epitope - Implikationen für den Supertyp
Identifizierung HLA-C restringierter HIV-1 spezifischer CTL Epitope mittels Peptid induzierter Hochregulierung der HLA-C-Expression
Neue HLA-Liganden und T-Zell-Epitope für die Immuntherapie des Bronchialkarzinoms
Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis
Ligand classification on the example of HLA subtype specific binding epitope prediction
Computer Aided Drug Discovery Descriptor Improvement and Application to Obesity-related Therapeutics : Computer Aided Drug DiscoveryDescriptor Improvement and Application to Obesity-related Therapeutics
Animal models for human cancer : discovery and development of novel therapeutics
Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale
Epitope recognition since Landsteiner's discovery : 100 years since the discovery of human blood groups ; with 11 tables
Interactions of HLA-DR and Topoisomerase I Epitope Modulated Genetic Risk for Systemic Sclerosis
The Role of Mass Spectrometry and Proteogenomics in the Advancement of HLA Epitope Prediction
ImmuneApp for HLA-I epitope prediction and immunopeptidome analysis
Charakterisierung HLA-A*01- sowie HLA-A*26-restringierter EBV-Epitope - Implikationen für den Supertyp
Identifizierung HLA-C restringierter HIV-1 spezifischer CTL Epitope mittels Peptid induzierter Hochregulierung der HLA-C-Expression
Neue HLA-Liganden und T-Zell-Epitope für die Immuntherapie des Bronchialkarzinoms
Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis
Ligand classification on the example of HLA subtype specific binding epitope prediction
Computer Aided Drug Discovery Descriptor Improvement and Application to Obesity-related Therapeutics : Computer Aided Drug DiscoveryDescriptor Improvement and Application to Obesity-related Therapeutics
Animal models for human cancer : discovery and development of novel therapeutics
Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale
Epitope recognition since Landsteiner's discovery : 100 years since the discovery of human blood groups ; with 11 tables
Interactions of HLA-DR and Topoisomerase I Epitope Modulated Genetic Risk for Systemic Sclerosis
The Role of Mass Spectrometry and Proteogenomics in the Advancement of HLA Epitope Prediction
ImmuneApp for HLA-I epitope prediction and immunopeptidome analysis
Charakterisierung HLA-A*01- sowie HLA-A*26-restringierter EBV-Epitope - Implikationen für den Supertyp
Identifizierung HLA-C restringierter HIV-1 spezifischer CTL Epitope mittels Peptid induzierter Hochregulierung der HLA-C-Expression
Neue HLA-Liganden und T-Zell-Epitope für die Immuntherapie des Bronchialkarzinoms
Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis
Ligand classification on the example of HLA subtype specific binding epitope prediction
Computer Aided Drug Discovery Descriptor Improvement and Application to Obesity-related Therapeutics : Computer Aided Drug DiscoveryDescriptor Improvement and Application to Obesity-related Therapeutics
Animal models for human cancer : discovery and development of novel therapeutics
Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale
Epitope recognition since Landsteiner's discovery : 100 years since the discovery of human blood groups ; with 11 tables
Interactions of HLA-DR and Topoisomerase I Epitope Modulated Genetic Risk for Systemic Sclerosis